Maravai LifeSciences (MRVI) Social Stream
MARAVAI LIFESCIENCES HOLDINGS INC (MRVI) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering MRVI.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-19 | 8 | $62 | $32 | $53.428 | $13.67 | 290.84% |
| 2021-11-11 | 8 | $65 | $49 | $56.166 | $13.67 | 310.87% |
| 2022-01-23 | 6 | $65 | $49 | $56.166 | $13.67 | 310.87% |
| 2022-02-08 | 6 | $59 | $42 | $52.333 | $13.67 | 282.83% |
| 2022-02-24 | 6 | $58 | $42 | $48.5 | $13.67 | 254.79% |
| 2022-05-06 | 6 | $54 | $40 | $46.2 | $13.67 | 237.97% |
| 2022-05-09 | 6 | $49 | $40 | $44.333 | $13.67 | 224.31% |
| 2022-05-20 | 6 | $49 | $40 | $43.833 | $13.67 | 220.65% |
| 2022-07-19 | 7 | $49 | $35 | $42.571 | $13.67 | 211.42% |
| 2022-08-05 | 7 | $40 | $30 | $35.571 | $13.67 | 160.21% |
| 2022-08-13 | 7 | $40 | $30 | $34.428 | $13.67 | 151.85% |
| 2022-10-23 | 7 | $37 | $30 | $34 | $13.67 | 148.72% |
| 2022-11-04 | 7 | $35 | $17 | $26.428 | $13.67 | 93.33% |
| 2022-12-07 | 8 | $32 | $17 | $23.75 | $13.67 | 73.74% |
| 2023-01-03 | 9 | $32 | $17 | $23.888 | $13.67 | 74.75% |
| 2023-02-08 | 10 | $32 | $16 | $23.1 | $13.67 | 68.98% |
| 2023-02-24 | 10 | $32 | $15 | $21.9 | $13.67 | 60.2% |
| 2023-03-01 | 11 | $32 | $15 | $21.6 | $13.67 | 58.01% |
The Trend in the Analyst Price Target
MRVI's average price target has moved down $11.54 over the prior 27 months.
MRVI reports an average of 56.94% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-09-05 | 7 | 37 | 30 | 34.0 | 20.87 | 62.91% |
| 2022-10-23 | 7 | 37 | 30 | 34.0 | 16.68 | 103.84% |
| 2023-01-27 | 10 | 32 | 16 | 23.1 | 14.50 | 59.31% |
| 2023-02-08 | 10 | 32 | 16 | 23.1 | 14.24 | 62.22% |
| 2023-02-24 | 11 | 32 | 15 | 21.6 | 14.36 | 50.42% |
MRVI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 7 | 2 | 2 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
MRVI's average broker recommendation rating worsened by 0.05 over the prior 27 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MRVI as an investment opportunity.
- In the context of all US stocks, MARAVAI LIFESCIENCES HOLDINGS INC's upside potential (average analyst target price relative to current price) is higher than 1794% of them.
- MRVI has a greater number of analysts covering the stock than 351.7% of stocks in the large market cap category.
- To contextualize these metrics, consider that out of stocks in the large market cap category, MARAVAI LIFESCIENCES HOLDINGS INC's average analyst price target is higher than 501.34% of them.
- In the context of stocks in the large market cap category, MARAVAI LIFESCIENCES HOLDINGS INC's variance in analysts' estimates is lower than -941.87% of them.
Stocks similar to MARAVAI LIFESCIENCES HOLDINGS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ABCL, RVMD, and BEAM.
View All Top Stocks by Price Target
What is the outlook for MRVI? Use POWR Ratings for clearer insight into price direction.